Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Protein, S.A. is a Spanish biotechnology company specializing in the research, development, and production of hydrolyzed collagen and protein-based ingredients for the healthcare and nutraceutical industries. Founded in 1976 and headquartered in Girona, the company is a pioneer in the field of bioactive collagen peptides, which it markets under the flagship brand Colpropur. Its products are primarily designed to support joint and bone health, skin rejuvenation, and sports nutrition, with a strong emphasis on clinical validation. In 2022, Protein, S.A. was acquired by Darling Ingredients, integrating its operations into the global Rousselot business unit. The company continues to operate its advanced manufacturing facilities in Spain, supplying high-quality protein solutions to international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Protein SA.